Microduplication Xp11.22p11.23 syndrome

Microduplication Xp11.22p11.23 syndrome is a rare chromosomal anomaly characterized by a small duplication of genetic material on the short arm of the X chromosome, specifically in the Xp11.22 to Xp11.23 region. This condition primarily affects neurodevelopment and can manifest differently depending on the sex of the affected individual. Males tend to be more severely affected than females due to having only one X chromosome. The key clinical features of this syndrome include intellectual disability of variable severity, developmental delay (particularly speech and language delay), behavioral abnormalities, and in some cases, seizures. Affected individuals may also present with mild dysmorphic facial features, though these can be subtle and nonspecific. Some patients exhibit features overlapping with autism spectrum disorder or attention deficit hyperactivity disorder. The neurological and cognitive systems are the most prominently affected body systems, though additional features involving growth and other organ systems have been variably reported. There is currently no specific cure or targeted treatment for microduplication Xp11.22p11.23 syndrome. Management is supportive and symptom-based, including early intervention programs, speech therapy, occupational therapy, behavioral therapy, and special educational support. Seizures, when present, are managed with standard antiepileptic medications. Genetic counseling is recommended for affected families to understand recurrence risks and the variable expressivity of this condition, particularly given its X-linked nature.

Common questions about Microduplication Xp11.22p11.23 syndrome